Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP was delisted on the 13th of August, 2018.
42 hedge funds and large institutions have $18.1M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
66% more call options, than puts
Call options by funds: $497K | Put options by funds: $300K
28% more capital invested
Capital invested by funds: $14.2M → $18.1M (+$3.91M)
14% more funds holding
Funds holding: 37 → 42 (+5)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$578K |
| 2 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$536K |
| 3 |
Renaissance Technologies
New York
|
+$466K |
| 4 |
DMK
David M. Knott
|
+$413K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$285K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$388K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$287K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$231K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$108K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$101K |
JNP Hedge Fund Activity: Q1 2015 in Review
42 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Juniper Pharmaceuticals, Inc. Common Stock (JNP) for Q1 2015, worth a combined $18.1M — up 28% from $14.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new JNP positions and 3 closed out — a net gain of 5 holders — while 11 added to existing stakes and 12 trimmed.
The largest buyer was JW Asset Management, adding an estimated $578K. The largest seller was Royal Bank of Canada, cutting an estimated $388K.
- 42 institutional investors held Juniper Pharmaceuticals, Inc. Common Stock (JNP) as of Q1 2015, up from 37 in Q4 2014.
- Funds reported $18.1M of Juniper Pharmaceuticals, Inc. Common Stock stock for Q1 2015, up 28% quarter-over-quarter.
- 8 funds opened new Juniper Pharmaceuticals, Inc. Common Stock positions in Q1 2015 and 3 closed out, a net change of +5 holders.
- The largest Juniper Pharmaceuticals, Inc. Common Stock buyer in Q1 2015 was JW Asset Management, an estimated $578K added.
- The largest Juniper Pharmaceuticals, Inc. Common Stock seller in Q1 2015 was Royal Bank of Canada, an estimated $388K sold.
Based on aggregated 13F filings for Q1 2015.